首页 › 基金 › Simplify Asset Management Inc. › ARQT
Simplify Asset Management Inc. 对 ARQT 的持仓历史
ARCUTIS BIOTHERAPEUTICS INC · 医疗保健
Simplify Asset Management Inc. 在 Q3 2026 的 13F 申报中披露持有 ARQT(ARCUTIS BIOTHERAPEUTICS INC)865,862 股,市值约 US$22.9M,约占其申报组合的 0.38%,在其申报持仓中市值排名第 13 位。 Simplify Asset Management Inc. 最近 8 个申报季度中有 5 个季度披露了 ARQT 持仓,最早可追溯至 Q4 2024。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Simplify Asset Management Inc. 对 ARQT 的持仓演变
Simplify Asset Management Inc. 于 Q4 2024 首次披露 ARQT 持仓:742,299 股(约 US$10.3M)。 该持仓在 Q3 2026 达到峰值 865,862 股,市值约 US$22.9M。 在 5 次申报中,Simplify Asset Management Inc. 0 次增持、3 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 865,862 股、市值约 US$22.9M。 持仓曾出现大幅变动:Q2 2025 减持约 38% (随后一个季度股价上涨 34%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2024 | 742.30K | $10.34M | 新进 |
| Q1 2025 | 660.56K | $10.33M | 减持 |
| Q2 2025 | 409.43K | $5.74M | 减持 |
| Q3 2025 | 318.00K | $5.99M | 减持 |
| Q3 2026 | 865.86K | $22.88M | 新进 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ARQT 与 13F 数据
ARQT(ARCUTIS BIOTHERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 46 只申报持有 ARQT,申报仓位最大的包括:MONTANOVA CAPITAL, LLC (US$326.1M), Frazier Life Sciences Management, L.P. (US$258.9M), Rubric Capital Management LP (US$216.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ARQT 的基金
- MONTANOVA CAPITAL, LLC 12.44M 股 · $326.10M · Q2 2026
- Frazier Life Sciences Management, L.P. 9.87M 股 · $258.91M · Q2 2026
- Rubric Capital Management LP 8.27M 股 · $216.88M · Q2 2026
- ORBIMED ADVISORS LLC 2.04M 股 · $53.54M · Q2 2026
- OBERWEIS ASSET MANAGEMENT INC/ 1.37M 股 · $36.00M · Q2 2026
- Pivotal bioVenture Partners Investment Advisor LLC 1.27M 股 · $33.18M · Q2 2026
更多关于 Simplify Asset Management Inc.
常见问题
How long has Simplify Asset Management Inc. held ARQT?
Simplify Asset Management Inc. has disclosed ARQT holdings in 5 of the last 8 reported quarters, going back to Q4 2024.
What is Simplify Asset Management Inc.'s current position in ARQT?
As of Q3 2026, Simplify Asset Management Inc. holds 865.86K shares of ARQT (ARCUTIS BIOTHERAPEUTICS INC), valued at $22.88M, representing 0.38% of its reported portfolio and ranking #13.
Has Simplify Asset Management Inc. been buying or selling ARQT?
In the latest 13F filing (Q3 2026), Simplify Asset Management Inc. newly opened its position in ARQT. The position peaked in Q3 2026 at 865.86K shares.
Which other funds hold ARQT?
Other major institutional holders of ARQT include MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., Rubric Capital Management LP, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.